MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA

This adverse event was reported 54 times

MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IMETELSTAT SODIUM 1 0.0054
1 SELUMETINIB 1 0.0006
2 VALGANCICLOVIR 10 0.0005
3 INFLIXIMAB-DYYB 1 0.0003
4 LARONIDASE 1 0.0002
5 DECITABINE 1 0.0002
6 ZANUBRUTINIB 1 0.0002
7 SACITUZUMAB GOVITECAN 1 0.0002
8 MYCOPHENOLATE MOFETIL 16 0.0001
9 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 16 0.0001
See all drugs enriched for association with MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA